SYNOPSIS From surveys conducted by the authors it is concluded that the best and most acceptable quality control methods in cytology are those from within the laboratory. Most Table I demonstrates not only the wide scatter of results presented in the literature but also the range of lesions being assessed, the various methods of sample collection, and the very wide variety of methods used to calculate the results. All this makes comparisons difficult. False negative rates are usually underestimated because they are only discovered when abnormal histology or an abnormal smear follows a previous negative smear. The mobility of populations and failure of follow up can prevent this information reaching the laboratory which put out the false negative report and so prevent complete accuracy when false negative rates are circulated. It is only when a second smear is taken as in the Christie Hospital series that the resulting figures are a true measure of the false negative rate. Errors can occur at all stages and these will be considered under the following headings: (1) biological variability; (2) collection of samples
The problem of quality control in cytology is complex. In the first place it must be quite clear what quality is being controlled. Essentially, it is the accuracy of diagnosis of cancer or precancer; or, conversely, the certainty of its absence. There are, however, many shades of grey in this diagnosis due to the need to recognize the wide range of dysplasia and carcinoma in situ as well as invasive cancer. In addition, there is the need to appreciate indirect evidence of neoplasia such as unexplained cellular debris or unusual hormonal patterns, as these features can contribute to the quality of the final report, Cytopathology, like histopathology, is a subjective discipline. In the final analysis all cytological reports are the opinion of one person and are in turn monitored by the opinion of a colleague reporting on histological sections from the same patient. To maintain a reasonable uniformity of quality of cytology reports throughout the country, proper training of cytopathologists is of first importance, but it is also important that all those involved in cytology should be aware of the areas of potential error which can lead to inaccuracy.
Control of the quality of collection, preparation, screening, and interpretation is of importance in all branches of cytology, but this paper deals primarily 'This is a compilation of data from a lecture given to publicationlO September 1974 with the problem of detection of malignant and premalignant disease of the uterine cervix. A number of surveys have demonstrated the wide range of error rates for this condition where the false negative rate varies from 1-1 to 30% (table I) . Table I demonstrates not only the wide scatter of results presented in the literature but also the range of lesions being assessed, the various methods of sample collection, and the very wide variety of methods used to calculate the results. All this makes comparisons difficult. False negative rates are usually underestimated because they are only discovered when abnormal histology or an abnormal smear follows a previous negative smear. The mobility of populations and failure of follow up can prevent this information reaching the laboratory which put out the false negative report and so prevent complete accuracy when false negative rates are circulated. It is only when a second smear is taken as in the Christie Hospital series that the resulting figures are a true measure of the false negative rate. Errors can occur at all stages and these will be considered under the following headings: (1) biological variability; (2) collection of samples (a, site, b, sampling method); (3) laboratory procedures (a, processing, b, screening, c, interpretation) . Survey Percentage False Negative Rate Graham and Meigs (1949) Vaginal aspirate 10-0 Scheffey (1949) 30 0 Reduced by multiple screening to
17-6
Achenbach et al (1951) Vaginal aspirate Cuyler et al (1951) Dysplasia-invasive carcinoma 9-2-12 8
Reagan and Hicks (1953) 5-0
Fidler et al (1957) Squamous cell carcinoma 6-5 Friedell et al (1960) Vaginal aspirate 19-0 Cervical os aspirate 11 0 Soule and Dahlin (1960) 2-4 Richart (1964) Initial smear positive (table II) . Failure of exfoliation is more common in postmenopausal women as was found by Butler and Frost in their review of material reported by Silbar and Woodruff (1966) . In this series 120% of women with false negative smears were postmenopausal, while of the women with positive or suspicious smears only 5.4% were postmenopausal (Butler, 1973 Macgregor, Fraser, and Mann (1966) . Wied (1955) found that with carcinoma in situ of the cervix the vaginal aspirate contained only 2-5 abnormal cells per 100 normal cells compared with 35 abnormal cells in the ectocervical scrape, and 110 abnormal cells in the endocervical swab smear. Choice of a method which gives maximum exfoliation becomes even more important if earlier lesions such as dysplasia are to be detected. Husain (1970) found that the irrigation pipette detected 65 to 70% of cases with dysplasia and 85 % of cases with carcinoma in situ in comparison with 100% detection using a cervical scrape smear in the same cases. When numbers of abnormal cells were counted in smears collected by the two methods the rates were between 10 and 50 times less using the irrigation pipette (Husain, unpublished results) .
In the Aberdeen series (J.E.M.) a comparison was made of the effectiveness of the detection of cancer and precancer of the cervix using cervical and vaginal smears (table III) . Both smears were equally positive in 19 2 % of the 61 cases studied but in 69 % the cervical smear contained more abnormal cells while the vaginal smear was the more abnormal in only 6.9 % of cases.
Other workers have described similar results. (Gondos, Marshall, and Ostergard, 1972 Quality control of cervical cytology in the Christie Hospital and Holt Radium Institute has taken the form of a randomized recall of 10 % of women, whose first smears were reported as normal and satisfactory, after an interval of three months. The computerized records system makes it possible to do this with comparative ease. As the interval between the two smears is so short, the second smear acts as a check or control on the first: it is assumed that the 'positive smear state' will not arise anew during such a short interval. An analysis of 14 437 women who responded to the request to have a further test at three months is given in tables IV and V. 
SCREENING
The screening of cytology smears is a most important area for quality control and the training of the cytotechnician who does this work is as important as the training of the pathologist who signs out the final report. In many laboratories the volume of work is such that most smears considered to be 'negative' are seen only by an experienced cytotechnician although the histories and the reports are checked by the pathologist as credible and appropriate. This places considerable responsibility on the screener. In addition to recognizing any abnormality she must be fully aware of all the features which make a smear 'unsatisfactory' or, what is more difficult, be able to recognize a suboptimal sample.
The recent publication by the World Health Organization states that: 'Artefacts and preparations that are unsatisfactory for a variety of reasons such as drying and paucity of material are a recurring problem. Since attempts at interpreting such preparations often lead to diagnostic errors, they must be rejected as unsatisfactory, and a repeat smear requested' (Riotton and Christopherson, 1973 of doctors on rota at these clinics. The lowest unsatisfactory rates and the highest detection rates came from a population survey group in which the same doctor collected and examined the smears. However, the detection rates in the series cannot be compared as each group varies for age and parity. The screener is also responsible for the primary detection of any abnormal cells in a smear. In the Christie Hospital series 0-6 per 1000 cases, ie, 6% of smears containing identifiable neoplastic cells, were missed on screening. Most laboratories have some system of internal control to mitigate this problem. The usual cause is loss of concentration due to fatigue rather than inability to recognize abnormal cells. A review of cases in which cells have been missed shows that they are usually smears with heavy inflammation, when greater alertness is needed or, paradoxically, thin clean smears. In the latter case it seems likely that there is a false sense of security that this is an easy smear and screening is done too quickly. Long hours at the microscope are fatiguing and no screener should be pressed to work faster than her optimum speed. It is also necessary to allow for short rest breaks. When technicians work full time in cytology it is inadvisable for them to spend the whole day at the microscope; it is better if they can spend part of the time on other duties. In addition to care for the wellbeing of the screener, various methods of double screening have been suggested: in some laboratories all smears are screened twice. This needs either a very large staff or very fast screening which is perhaps self-defeating.
There has been an argument for instituting a 10% rescreening check on negative smears and this has been the accreditation requirement of the American Center for Disease Control and the American Society of Cytology.
Dr M. R. Melamed in his Presidential Address to the American Society of Cytology has demonstrated that to detect a screener with a more than 10% failure rate and reading over 10 000 smears per year, then with a positive smear rate of 5 per 1000 population, it would take 13 years, and if the positive rate were 1 per 2000 (which is happening in rescreening of populations at yearly intervals) then it could take 66 years to identify an unreliable screener (Melamed, 1973) .
In a large screening laboratory it might be possible to use the method advocated by Dr M. Rodney of the Cancer Screening Service, California (Rodney, 1972) . He recycles the abnormal smears from the previous day into the current day's workload. A graph composed of the positive discriminative performance rate (PDP) and the code grade of each screener is printed out from the computer data and posted on the notice board. This laboratory screens 3000 smears per day and there are 32 screeners, so that it is easy to arrange that a smear will not be rescreened by the same technician. Although less easy to carry out, a somewhat similar practice could be established even in the small hospital laboratory (Rodney, 1973 Any analysis of the accuracy of cytology reporting is monitored by the histological report and this is also a subjective discipline. Correlation will be closest if cytology and histology are reported by the same person, but then there is danger of individual bias occurring. The greatest disparity is found when related histology is reported by a number of laboratories, none of which is in close contact with the cytology laboratory. Problems arise because biopsy material can be inadequate. This was found in 8-5 % of the cases reviewed by Govan, Haines, Langley, Taylor, and Woodcock (1966) . In addition there was some divergence of opinion between the views of the panel and the views of the submitting pathologist. The variation in opinion between pathologists reporting on abnormalities of cervical epithelium is also a problem (Holmquist, McMahan, and Williams, 1967) . Cocker, Fox, and Langley (1968) compared the opinions of three pathologists working in the same laboratory and using the same diagnostic criteria. They also found a 'drift' when the reports of one of the pathologists were compared with his reports on the same material after an interval oftime.
Discrepancies between cytology and histology can also arise when the lesion is small. In these cases it is possible that the abnormal area is not present in any of the sections examined. This was found by Nichols, Boyes, and Fidler (1968) At St Mary's Hospital, Manchester (E.B.B.), the bulk of the cervical cytology comes from patients attending the hospital clinics, and the histology is reported in a closely linked department by a consultant other than the cytopathologist. Cervical smears are reported to indicate the expected histopathology, and reports of lesions of squamous epithelium fall into one of the following categories: (1) invasive squamous cell carcinoma; (2) borderline invasion/carcinoma in situ or suspicious of invasion; (3) carcinoma in situ; (4) borderline carcinoma in situ/dysplasia; (5) dysplasia; and (6)' borderline' dysplasia/benign lesion.
This method allows for precise correlation with the histological report. When discrepancies occur, both cytological and histological material is reviewed and errors in interpretation are identified. In some cases, examination of further sections demonstrates the presence of a more advanced abnormality, while in others loss of epithelium from the cervix prevents a final diagnosis being made. An attempt is always made to find the abnormal cells seen in the smear in their place in the histological pattern. In addition to promoting a detailed study of cellular morphology, the exercise as a whole indicates the problem areas in diagnosis.
During gists (Cocker et al, 1968) . In this series the tendency was to underestimate carcinoma in situ and to overestimate severe dysplasia. The advantage of the association of these two lesions in the coding of the national form is made apparent. In any study of quality control throughout the country it is important to know how much variation there is in reports given on the same smear from one cytology laboratory to another. One of us (D.M.D.E.) circulated 100 smears to five well established centres in England and Wales for a report using the following codes: normal, atypical, dyskaryotic, suspicious of malignancy, positive for malignancy (Evans and Sanerkin, 1970 
